Trump's 2026 fiscal year budget request doesn't just disappoint cannabis advocates—it represents a masterclass in political bait-and-switch. After months of suggesting he'd take a more reasonable approach to cannabis policy, Trump is proposing to delete the longstanding rider that prevents the Justice Department from interfering with state medical marijuana programs. This isn't just policy—it's betrayal of millions of Americans who rely on medical cannabis for serious health conditions.

A recent study published in Health Economics provides a smoking gun that prohibition apologists would prefer you ignore. Researchers found that cannabis legalization reduces prescription drug spending by approximately 6% in small group insurance markets, with the effect growing stronger over time. Translation: when people can legally access cannabis, they spend less money on Big Pharma's products.

In a stunning display of political theater disguised as child protection, the Texas House just voted to eliminate an $8 billion legal industry and hand it directly to Mexican and Chinese drug cartels. Senate Bill 3, which passed 95-44 late Wednesday night, bans virtually all THC products in Texas—effectively criminalizing an industry that employs thousands of Texans and serves millions of adults who prefer regulated products over black market alternatives.

One of Mavericks Genetics' core offerings is feminized seeds. These are specially bred to eliminate the guesswork in cultivation by producing only female plants. These are responsible for resin-rich, cannabinoid-heavy buds.

Just when you thought we'd moved past the era of "Reefer Madness" headlines, a new study has sent cannabis prohibitionists into overdrive. "Cannabis use in any form directly linked to significant risk of heart damage," screams the latest round of sensationalized reporting. The media machine has latched onto this research with the fervor of a temperance crusader finding a bottle of whiskey in Sunday school.

Until more definitive research emerges, the most honest answer to "Is the entourage effect real?" remains: "We think so, but we're still figuring out exactly how it works." That may not make for catchy marketing, but it's the closest thing to truth in our current state of knowledge.

In a groundbreaking pilot program, New Mexico is using cannabis tax revenue to provide no-strings-attached cash payments to residents, creating what may be the most innovative social welfare program in the United States. This isn't theoretical policy experimentation—it's a real program delivering real results to real people who need financial support the most.

THCA and THC are essentially the same thing. The former, however,  is THC’s acidic precursor with an additional molecular structure making it legally distinguishable from Delta-9 THC.

Based on the Sanctuary Wellness Institute survey and countless customer complaints across legal states, several cardinal sins plague the cannabis retail industry. Understanding these failures is the first step toward creating a superior customer experience.

The Drug Enforcement Administration (DEA)—an agency ostensibly created to protect Americans from dangerous substances—is actively blocking a legitimate pharmaceutical company from developing federally-compliant cannabis medications while simultaneously admitting it can't stop illegal cartel operations in states with legal cannabis.